IRTC - NASDAQ

iRhythm Technologies, Inc.

IRTC·NASDAQ

$104.56

+1.5%

HealthcareMedical - Devices

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$3.44B

EPS-1.3900

P/E Ratio-75.22

Earnings Date07/30/2026

1.02B

Assets

10%

3Y+128.0%

5Y+99.0%

10Y+638.0%

867.30M

Total Liabilities

3Y+316.0%

5Y+410.0%

10Y+1802.0%

152.75M

Total Equity

68%

3Y-36.0%

5Y-55.0%

10Y+65.0%

iRhythm Technologies, Inc. Funding & Solvency Profile

IRTC · NASDAQ

Current Assets

Cash & Cash Equivalents236.01M

Net Receivables75.71M

Inventory21.63M

Other Current Assets21.66M

Total Current Assets703 M

Non-Current Assets

Property, Plant & Equipment193.43M

Goodwill & Intangible Assets862.00K

Long-Term Investments69.91M

Other Non-Current Assets53.08M

Total Non-Current Assets316 M

Total Assets

1.02B

Financial Health Analysis

Current Ratio

4.63x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

5.68x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

551 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

69% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.

iRhythm Technologies, Inc. Balance Sheet

IRTC • NASDAQ

iRhythm Technologies, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	236M	419.6M	36.2M	78.8M	127.6M	88.6M	20.5M	20M	8.7M	51.6M	25.2M	8.6M	7.1M
Short-Term Investments	347.8M	116M	97.6M	134.3M	111.6M	246.6M	120.1M	58.3M	93.7M	54.4M	0.0	0.0	0.0
Cash & Short-Term Investments	583.8M	535.6M	133.8M	213.1M	239.1M	335.2M	140.6M	78.3M	102.4M	106.1M	25.2M	8.6M	7.1M
Net Receivables	75.7M	79.9M	61.5M	49.9M	46.4M	29.9M	23.9M	19.8M	13M	9.4M	5.6M	5.9M	3.7M
Accounts Receivables	75.7M	79.9M	61.5M	49.9M	46.4M	29.9M	23.9M	19.8M	13M	9.4M	5.6M	5.9M	3.7M
Inventory	21.6M	14M	14M	15.2M	10.3M	5.3M	4M	2.1M	1.7M	1.4M	1.1M	818K	747K
Prepaids	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1M	2.6M	1.7M	808K	243K	208K
Other Current Assets	21.7M	16.3M	21.6M	10.6M	9.7M	7.4M	4.3M	4.1M	2.6M	91K	91K	0.0	0.0
Total Current Assets	702.8M	645.8M	230.8M	288.8M	305.5M	377.8M	172.8M	106.5M	119.6M	118.6M	32.8M	15.5M	11.7M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	193.4M	172.7M	153.4M	136.3M	140.5M	119M	116.6M	9.2M	6.2M	4.7M	2M	751K	403K
Goodwill	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K
Goodwill & Intangible Assets	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K	862K
Long-Term Investments	69.9M	61.9M	3M	0.0	0.0	0.0	8M	0.0	3M	11M	0.0	0.0	0.0
Other Non-Current Assets	53.1M	50.2M	45M	22.3M	16.1M	14.1M	7.9M	3.2M	3.5M	3.1M	2.1M	1.4M	255K
Total Non-Current Assets	317.3M	285.6M	202.3M	159.5M	157.4M	133.9M	133.4M	13.2M	13.5M	19.5M	5M	3M	1.5M
Total Assets	1B	931.4M	433.1M	448.2M	463M	511.7M	306.2M	119.7M	133.1M	138.2M	37.9M	18.5M	13.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	2.3M	7.2M	13M	9.9M	10.5M	4.4M	8.2M	2.3M	2.4M	2.1M	1.5M	1.2M	494K
Accounts Payable	2.3M	7.2M	5.5M	7.5M	10.5M	4.4M	8.2M	2.3M	2.4M	2.1M	1.5M	1.2M	494K
Other Payables	0.0	0.0	7.5M	2.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	49.8M	74.9M	44.4M	42.9M	26.6M	23M	21M	14.4M	9.9M	6.8M	3.2M	1.9M
Short Term Debt	16.7M	0.0	0.0	0.0	11.7M	11.7M	1.9M	0.0	1.5M	0.0	0.0	0.0	1.6M
Capital Lease Obligations (Current)	0.0	15.9M	15.2M	13M	11.1M	8.2M	7.9M	0.0	0.0	0.0	0.0	0.0	-243K
Tax Payables	0.0	4M	2.9M	2.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	4.2M	2.9M	3.3M	3.1M	3M	930K	1.3M	1.2M	1.2M	947K	506K	0.0	0.0
Other Current Liabilities	128.7M	35.1M	1M	18.7M	8.6M	14M	9.7M	5.8M	1.4M	257K	0.0	421K	28K
Total Current Liabilities	151.9M	110.9M	107.4M	89.1M	87.9M	65.7M	52.1M	30.2M	20.9M	13.2M	8.8M	4.9M	4.3M
NON-CURRENT LIABILITIES
Long Term Debt	714.5M	646.4M	35M	34.9M	9.7M	21.3M	33M	34.9M	32.5M	32.2M	30.6M	6.3M	4.2M
Other Non-Current Liabilities	908K	8.6M	1M	1.3M	697K	1.8M	0.0	153K	161K	152K	100.2M	130K	190K
Total Non-Current Liabilities	715.4M	729.6M	115.7M	119.3M	95.6M	104.5M	118.7M	35.1M	32.7M	32.4M	130.7M	6.4M	4.4M
Capital Lease Obligations	0.0	90.5M	94.9M	96.1M	96.4M	89.5M	93.7M	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	867.3M	840.5M	223M	208.4M	183.5M	170.1M	170.8M	65.3M	53.6M	45.6M	139.5M	11.2M	8.7M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	-25M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-4.6M	0.0	0.0
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.1M	0.0	100M	87.8M	70.2M
Common Stock	32K	31K	31K	28K	27K	27K	25K	23K	23K	22K	1K	8K	8K
Additional Paid-In Capital	0.0	874.6M	855.8M	762.4M	685.6M	646.3M	395.7M	258M	236.2M	219.7M	4.6M	2.9M	2M
Retained Earnings	-803.4M	-758.9M	-645.6M	-522.2M	-406M	-304.7M	-260.4M	-203.5M	-156.6M	-127.2M	-106.3M	-83.5M	-67.6M
Accumulated Other Comprehensive Income/Loss	403K	165K	-112K	-396K	-61K	11K	82K	-41K	-65K	-9K	-1.1M	0.0	0.0
Other Total Stockholders' Equity	955.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-94.3M	0.0	0.0
Total Stockholders' Equity	152.7M	90.9M	210.1M	239.8M	279.5M	341.6M	135.4M	54.4M	79.6M	92.6M	-101.6M	7.3M	4.6M
Total Equity	152.7M	90.9M	210.1M	239.8M	279.5M	341.6M	135.4M	54.4M	79.6M	92.6M	-101.6M	7.3M	4.6M
SUMMARY
Total Liabilities & Equity	1B	931.4M	433.1M	448.2M	463M	511.7M	306.2M	119.7M	133.1M	138.2M	37.9M	18.5M	13.3M
Total Investments	417.7M	177.9M	100.6M	134.3M	111.6M	246.6M	128.1M	58.3M	96.7M	65.4M	0.0	0.0	0.0
Total Debt	731.2M	736.9M	129.8M	131M	117.7M	122.5M	128.6M	34.9M	34M	32.2M	30.6M	6.3M	5.8M
Net Debt	495.2M	317.3M	93.7M	52.2M	-9.9M	33.8M	108.1M	14.9M	25.3M	-19.4M	5.3M	-2.4M	-1.3M
Shares Outstanding	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719	32,218,719

SEC Filings

IRTC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 28, 2026	May 27, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	April 17, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	April 01, 2026	March 30, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 12, 2026	March 12, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 19, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 19, 2026	February 19, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 12, 2025	November 12, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 30, 2025	October 30, 2025	2025	View Filing

Showing 1 to 10 of 172 filings

Related Guides

Blog Categories

Continue your IRTC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.